UNIVERSAL HEALTH SVCS ($UHS) posted quarterly earnings results for Q4 2025 on Wednesday, February 25th. The company reported earnings of $5.88 per share, missing estimates of $5.96 by $0.08. The company also reported revenue of $4,486,050,000, missing estimates of $4,547,140,482 by $-61,090,482.
Stock price change since market close: -5.95%
You can see Quiver Quantitative's $UHS stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
UNIVERSAL HEALTH SVCS Insider Trading Activity
UNIVERSAL HEALTH SVCS insiders have traded $UHS stock on the open market 3 times in the past 6 months. Of those trades, 0 have been purchases and 3 have been sales.
Here’s a breakdown of recent trading of $UHS stock by insiders over the last 6 months:
- WARREN J. NIMETZ has made 0 purchases and 2 sales selling 3,817 shares for an estimated $852,343.
- ELLIOT J MD MBA SUSSMAN sold 965 shares for an estimated $217,798
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
UNIVERSAL HEALTH SVCS Hedge Fund Activity
We have seen 347 institutional investors add shares of UNIVERSAL HEALTH SVCS stock to their portfolio, and 343 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 742,101 shares (-74.1%) from their portfolio in Q4 2025, for an estimated $161,792,860
- CITADEL ADVISORS LLC removed 662,975 shares (-97.7%) from their portfolio in Q4 2025, for an estimated $144,541,809
- PZENA INVESTMENT MANAGEMENT LLC added 505,575 shares (+31.5%) to their portfolio in Q4 2025, for an estimated $110,225,461
- NORGES BANK added 454,270 shares (+98.7%) to their portfolio in Q4 2025, for an estimated $99,039,945
- HOLOCENE ADVISORS, LP removed 358,885 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $78,244,107
- MORGAN STANLEY added 325,162 shares (+59.5%) to their portfolio in Q4 2025, for an estimated $70,891,819
- FIRST EAGLE INVESTMENT MANAGEMENT, LLC removed 307,588 shares (-6.7%) from their portfolio in Q4 2025, for an estimated $67,060,335
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
UNIVERSAL HEALTH SVCS Congressional Stock Trading
Members of Congress have traded $UHS stock 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $UHS stock by members of Congress over the last 6 months:
- REPRESENTATIVE JULIA LETLOW purchased up to $15,000 on 10/23.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
UNIVERSAL HEALTH SVCS Analyst Ratings
Wall Street analysts have issued reports on $UHS in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Wells Fargo issued a "Overweight" rating on 11/13/2025
- Guggenheim issued a "Buy" rating on 10/29/2025
- UBS issued a "Buy" rating on 10/29/2025
- Barclays issued a "Overweight" rating on 10/28/2025
To track analyst ratings and price targets for UNIVERSAL HEALTH SVCS, check out Quiver Quantitative's $UHS forecast page.
UNIVERSAL HEALTH SVCS Price Targets
Multiple analysts have issued price targets for $UHS recently. We have seen 8 analysts offer price targets for $UHS in the last 6 months, with a median target of $247.5.
Here are some recent targets:
- Andrew Mok from Barclays set a target price of $262.0 on 01/22/2026
- Stephen Baxter from Wells Fargo set a target price of $235.0 on 01/07/2026
- Ryan Langston from TD Cowen set a target price of $245.0 on 01/07/2026
- Jason Cassorla from Guggenheim set a target price of $274.0 on 12/02/2025
- Ben Hendrix from RBC Capital set a target price of $231.0 on 10/30/2025
- A.J. Rice from UBS set a target price of $302.0 on 10/29/2025
- Sarah James from Cantor Fitzgerald set a target price of $250.0 on 10/29/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
